Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Novoheart Holdings Inc. V.NVH

"Novoheart Holdings Inc is a Canadian based company. It is engaged in the engineering bio-artificial human heart tissues and chambers for drug discovery, cardiotoxicity screening, disease modeling and future therapeutic applications. Novoheart's scientific team has pioneered a range of bioengineering technologies collectively known as the MyHeart platform, including first human mini-heart... see more

TSXV:NVH - Post Discussion

Novoheart Holdings Inc. > Huge Day June 26th
View:
Post by Aberta1 on Jun 05, 2019 2:09pm

Huge Day June 26th

Special meeting NVH

Comment by imtheguy on Jun 10, 2019 5:57am
Nothing special. Just to approve the deal. Something smells of fish to me. They take over a new company with seems only a lot of money but no business. Anybody got an idea? Why? Fish t'm telling you. Maybe the TSX Venture will reject this seafood.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities